JONIRUTH DIGAUM: Open Payments
NPI 1881017382 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 15 payments from 8 companies in 2025. Trend: 2023 $509 · 2024 $905 · 2025 $500
Food & beverage: $390Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $279 |
| Vanda Pharmaceuticals Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Corium, LLC | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: UZEDY, FANAPT, AUSTEDO XR, COBENFY, INGREZZA, Azstarys, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across ID — which companies pay providers there.
